Singapore
September 9–10, 2025Marina Bay Sands, Singapore Shyam MasraniPrincipal at MedicxiSpeaker
Profile
Shyam is a Principal at Medicxi. Prior to joining Medicxi, Shyam founded two early-stage biotechnology companies (Shyden Biotechnology and Cleavr Therapeutics). He led Medicxi's investment in Merus (NASDAQ:MRUS) and ProfoundBio and currently serves on the boards of a number of portfolio companies, including T-Cypher Bio, My-T Bio, and CosMyc Therapeutics.
Shyam obtained a BSc in Biochemistry and a Masters in Translational Medicine from Imperial College London.
Agenda Sessions
Deals, breakthrough innovation, and partnering for biotech's next generation
, 11:00View Session